TSE:GMP - GMP Capital Stock Price, Price Target & More

Get Started

C$2.97 +0.03 (+1.02 %)

(As of 05/28/2018 06:00 AM ET)

Previous CloseC$2.97

Today's RangeC$2.91 - C$2.99

52-Week RangeC$2.13 - C$4.64

Volume28,200 shs

Average Volume143,115 shs

Market CapitalizationC$254.07 million

P/E RatioN/A

Dividend YieldN/A

Beta0.95

About GMP Capital (TSE:GMP)

GMP Capital Inc., an independent diversified financial services company, provides various financial products and services to corporate clients, institutional investors, and high-net-worth individuals in Canada, the United States, and internationally. It operates in two segments, Capital Markets and Wealth Management. The Capital Markets segment offers investment banking services, including advisory and underwriting services, institutional research and sales, and trading services. The Wealth Management segment provides wealth management and investment services. GMP Capital Inc. was founded in 1995 and is based in Toronto, Canada.

Receive GMP News and Ratings via Email

Sign-up to receive the latest news and ratings for GMP and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Independent Oil & Gas

Sub-IndustryN/A

SectorBasic Materials

SymbolTSE:GMP

CUSIPN/A

Webgmpcapital.com

Phone+1-416-3678600

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / CashN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net Margins-8.13%

Return on Equity-8.77%

Return on Assets-0.56%

Miscellaneous

EmployeesN/A

Outstanding Shares78,176,000

GMP Capital (TSE:GMP) Frequently Asked Questions

What is GMP Capital's stock symbol?

GMP Capital trades on the Toronto Stock Exchange (TSX) under the ticker symbol "GMP."

How were GMP Capital's earnings last quarter?

GMP Capital Inc. (TSE:GMP) issued its quarterly earnings results on Friday, March, 2nd. The company reported $0.11 earnings per share for the quarter. The business earned $59.30 million during the quarter. GMP Capital had a negative net margin of 8.13% and a negative return on equity of 8.77%. View GMP Capital's Earnings History.

When is GMP Capital's next earnings date?

GMP Capital is scheduled to release their next quarterly earnings announcement on Friday, August, 3rd 2018. View Earnings Estimates for GMP Capital.

Who are some of GMP Capital's key competitors?

Some companies that are related to GMP Capital include Calfrac Well Services (CFW), Hurricane Energy (HUR), Nostrum Oil & Gas (NOG), Athabasca Oil (ATH), Cooper Energy (COE), Ophir Energy (OPHR), Genel Energy (GENL), Faroe Petroleum (FPM), Sino Gas & Energy (SEH), Mainstreet Equity (MEQ), SOCO International (SIA), Karoon Gas Australia (KAR), Pieridae Energy (PEA), Byron Energy (BYE) and Lilis Energy (LLEX).

Who are GMP Capital's key executives?

GMP Capital's management team includes the folowing people:

Mr. Harris A. Fricker B.A., M.A., Pres, CEO & Director (Age 53)
Mr. Eugene C. McBurney B.A., M.A., LL.B., LL.D., Director (Age 69)
Ms. Deborah J. Starkman, Chief Financial Officer and Corp. Sec.
Mr. Robert Russell Weir, Vice-Chairman of GMP Securities and Head of Institutional Equity Sales of GMP Securities
Rocco Colella, Director of Investor Relations

Has GMP Capital been receiving favorable news coverage?

Press coverage about GMP stock has been trending somewhat positive recently, Accern Sentiment Analysis reports. The research firm identifies negative and positive press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. GMP Capital earned a news sentiment score of 0.18 on Accern's scale. They also gave headlines about the company an impact score of 46.85 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the near term.

How do I buy shares of GMP Capital?

Shares of GMP and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is GMP Capital's stock price today?

One share of GMP stock can currently be purchased for approximately C$2.97.

How big of a company is GMP Capital?

GMP Capital has a market capitalization of C$254.07 million.

How can I contact GMP Capital?

GMP Capital's mailing address is 145 King St W Suite 300, TORONTO, ON M5H 1J8, Canada. The company can be reached via phone at +1-416-3678600.

MarketBeat Community Rating for GMP Capital (GMP)

Community Ranking:		1.6 out of 5 ()
Outperform Votes:		76 (Vote Outperform)
Underperform Votes:		164 (Vote Underperform)
Total Votes:		240

MarketBeat's community ratings are surveys of what our community members think about GMP Capital and other stocks. Vote "Outperform" if you believe GMP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe GMP will underperform the S&P 500 over the long term. You may vote once every thirty days.

GMP Capital (TSE:GMP) Price Target and Consensus Rating

(How are Consensus Ratings Calculated?)

	Today	30 Days Ago	90 Days Ago	180 Days Ago
Consensus Rating:	N/A	N/A	Hold	Hold
Consensus Rating Score:	N/A	N/A	2.00	2.00
Ratings Breakdown:	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 0 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)	0 Sell Rating(s) 1 Hold Rating(s) 0 Buy Rating(s) 0 Strong Buy Rating(s)
Consensus Price Target:	N/A	N/A	C$5.00	C$5.00
Price Target Upside:	N/A	N/A	22.55% upside	22.55% upside

GMP Capital (TSE:GMP) Consensus Price Target History

Price Target History for GMP Capital (TSE:GMP)

GMP Capital (TSE:GMP) Analyst Ratings History

Show:

Date	Brokerage	Action	Rating	Price Target	Details
3/6/2017	Scotiabank	Reiterated Rating	Sector Perform	C$5.00
8/8/2016	CIBC	Boost Price Target	Sector Perform	C$5.00 ➝ C$6.00

(Data available from 5/28/2016 forward)

GMP Capital (TSE:GMP) Earnings History and Estimates Chart

Earnings by Quarter for GMP Capital (TSE:GMP)

GMP Capital (TSE:GMP) Earnings Estimates

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2018	1	$0.04	$0.04	$0.04

GMP Capital (TSE GMP) Earnings History by Quarter

Date	Quarter	Consensus Estimate	Actual EPS	Revenue Estimate	Actual Revenue	Release Link	Conference Call
8/3/2018
3/2/2018	Q4 2017		C$0.11		C$59.30 million	View	N/A
11/3/2017	Q3 2017		C($0.01)		C$34.30 million	View	N/A
8/4/2017	Q2 2017		C$0.01		C$44.40 million	View	N/A
4/27/2017	Q1 2017		C$0.07		C$77.41 million	View	N/A
3/3/2017	Q4 2016		C$0.08		C$65.20 million	View	N/A
11/2/2016	Q3 2016		C$0.01		C$43.50 million	View	N/A
8/5/2016	Q2 2016		C($0.02)		C$41.50 million	View	N/A
4/28/2016	Q1 2016	C($0.03)	C($0.07)		C$45.85 million	View	N/A
3/11/2016	Q4 2015	C($0.07)	C($0.21)		C$35.34 million	View	N/A
11/6/2015	Q3 2015	C($0.10)	C($0.12)		C$53.91 million	View	N/A
8/7/2015	Q2 2015	C$0.07	C$0.06		C$79.20 million	View	N/A
4/30/2015	Q1 2015	C($0.08)	C($0.10)		C$53.32 million	View	N/A
3/6/2015	Q4 2014	C$0.03	C($0.11)		C$52.80 million	View	N/A
11/7/2014	Q3 2014	C$0.03	C$0.03		C$75.81 million	View	N/A
8/8/2014		C$0.16	C$0.16		C$80.38 million	View	N/A
5/1/2014		C$0.05	C$0.07		C$63.87 million	View	N/A
3/4/2014	Q4 2013	C$0.14	C$0.11	C$71.10 million	C$67.77 million	View	N/A
11/8/2013	Q3 2013	C($0.01)	C($0.02)	C$48.75 million	C$42.60 million	View	N/A
8/9/2013	Q2 2013	C($0.01)	C($0.02)	C$53.30 million	C$60.32 million	View	N/A
3/1/2013	Q4 2012	C$0.07	C$0.17			View	N/A
8/3/2012	Q2 2012	C$0.01	C($0.06)			View	N/A
5/4/2012	Q1 2012	C$0.10	C($0.02)			View	N/A
3/14/2012	Q4 2011	C$0.06	C$0.03			View	N/A
11/4/2011	Q3 2011	C($0.10)	C($0.09)			View	N/A
8/5/2011	Q2 2011	C$0.20	C$0.04			View	N/A
5/6/2011	Q1 2011	C$0.32	C$0.34			View	N/A
3/2/2011	Q4 2010	C$0.36	C$0.50			View	N/A
11/5/2010	Q3 2010	C$0.20	C$0.32			View	N/A
8/6/2010	Q2 2010	C$0.26	C$0.30			View	N/A
5/7/2010	Q1 2010	C($0.10)	C$0.18			View	N/A
3/2/2010	Q4 2009	C$0.17	C$0.25			View	N/A
11/5/2009	Q3 2009	C$0.17	C$0.12			View	N/A
5/8/2009	Q1 2009	C$0.16	C$0.12			View	N/A
11/6/2008	Q3 2008		C$0.11			View	N/A
8/7/2008	Q2 2008		C$0.25			View	N/A
5/8/2008	Q1 2008	C$0.42	C$0.33			View	N/A
2/28/2008	Q4 2007	C$0.50	C$0.37			View	N/A

(Earnings results data provided by Zacks Investment Research)

GMP Capital (TSE:GMP) Dividend History by Quarter

Announced	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
4/30/2015		$0.0415		6/11/2015	6/15/2015	6/30/2015
3/5/2015	Quarterly	$0.0401	3.85%	3/12/2015	3/16/2015	3/31/2015
11/7/2014	quarterly	$0.05	3.11%	12/8/2014	12/10/2014	12/31/2014
9/8/2014	Quarterly	$0.05	2.38%	9/8/2014	9/30/2014	9/30/2014
6/6/2014	Quarterly	$0.05	2.53%	6/6/2014	6/30/2014	6/30/2014
3/12/2014	Quarterly	$0.05	2.52%	3/12/2014	3/31/2014	3/31/2014
11/7/2013		$0.0478		12/6/2013	12/10/2013	12/31/2013
12/6/2013	Quarterly	$0.05	3.31%	12/6/2013	12/31/2013	12/31/2013
5/3/2013	quarterly	$0.05			6/10/2013	6/30/2013

(Data available from 1/1/2013 forward)

GMP Capital (TSE GMP) Insider Trading and Institutional Ownership History

Insider Trading History for GMP Capital (TSE:GMP)

GMP Capital (TSE GMP) Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
12/14/2017	Robert Russell Weir	Director	Sell	30,434	C$2.81	C$85,519.54
8/31/2017	Chris Bond	Director	Buy	796	C$2.92	C$2,324.32
8/15/2017	Robert Russell Weir	Director	Buy	674	C$2.28	C$1,536.72
8/9/2017	Robert Russell Weir	Director	Buy	2,965	C$2.48	C$7,353.20
6/27/2017	Robert Russell Weir	Director	Buy	1,761	C$3.23	C$5,688.03
5/31/2017	Robert Russell Weir	Director	Buy	161	C$3.50	C$563.50
5/5/2017	Nicholas James Johnson	Director	Sell	87,500	C$3.50	C$306,250.00
3/22/2017	Nicholas James Johnson	Director	Sell	37,500	C$3.50	C$131,250.00
3/20/2017	Donald Arthur Wright	Director	Buy	1,000	C$3.70	C$3,700.00
3/15/2017	Donald Arthur Wright	Director	Buy	10,000	C$3.77	C$37,700.00
3/9/2017	David G Brown	Director	Buy	9,100	C$3.90	C$35,490.00
3/8/2017	David G Brown	Director	Buy	1,900	C$3.83	C$7,277.00
12/5/2016	Robert Russell Weir	Director	Buy	1,838	C$4.21	C$7,737.98
9/2/2016	Robert Russell Weir	Director	Buy	1,906	C$4.87	C$9,282.22
3/23/2016	James David Meekison	Director	Buy	5,000	C$4.81	C$24,048.00
3/21/2016	Christopher Hill	Director	Sell	26,220	C$4.65	C$121,962.33
3/15/2016	Donald Arthur Wright	Director	Buy	20,000	C$4.38	C$87,668.00
11/17/2015	Douglas Bell	Director	Sell	100,000	C$3.80	C$380,000.00
9/29/2015	Kevin M Sullivan	Director	Buy	4,563	C$4.09	C$18,681.38
9/8/2015	Kevin M Sullivan	Director	Buy	2,362	C$4.28	C$10,118.10
6/1/2015	Douglas Bell	Director	Buy	44,132	C$4.98	C$219,892.10
5/7/2015	Deborah Joanne Starkman	Director	Buy	15,000	C$5.00	C$74,965.50
3/10/2015	Fiona Louise Macdonald	Director	Buy	3,000	C$4.94	C$14,817.90

(Data available from 1/1/2013 forward)

GMP Capital (TSE GMP) News Headlines

Source:

Date	Headline
	Trenchant Closes Second Tranche of Prospectus Financing globenewswire.com - May 18 at 10:58 AM
	Bradmer Pharmaceuticals, Galaxy Digital and First Coin Announce Update and Distribution of Meeting Materials globenewswire.com - May 18 at 10:58 AM
	Input Capital's (INPCF) CEO Doug Emsley on Q2 2018 Results - Earnings Call Transcript seekingalpha.com - May 17 at 4:14 PM
	GMP Securities to Host 2018 Charity Trading Day in Support of Covenant House Toronto finance.yahoo.com - May 14 at 4:04 PM
	Valener's (VNRCF) CEO Sophie Brochu on Q2 2018 Results - Earnings Call Transcript seekingalpha.com - May 13 at 4:33 PM
	Vyriad to Build State-of-the-Art Facility for Manufacturing Oncolytic Virus Anti-Cancer Vaccines in Rochester, Minn. www.bizjournals.com - May 10 at 10:10 AM
	Canadian Banc Corp. Announces Successful Overnight Offering globenewswire.com - May 9 at 9:57 AM
	Goodfood Market Corp. Completes $10 Million Public Offering globenewswire.com - May 7 at 9:43 AM
	Bone Therapeutics Business Update for First Quarter 2018 globenewswire.com - May 4 at 9:47 AM
	Edited Transcript of GMP.TO earnings conference call or presentation 3-May-18 1:00pm GMT finance.yahoo.com - May 4 at 9:47 AM
	GMP Capital announces election of directors finance.yahoo.com - May 4 at 9:47 AM
	With ‘Dithering’ Hampering Oil Sector, GMP Capital Shifts to Pot finance.yahoo.com - May 3 at 4:04 PM
	ABcann Provides Business Update globenewswire.com - May 3 at 9:45 AM
	GMP Capital Inc. Reports First Quarter 2018 Results finance.yahoo.com - May 3 at 9:45 AM
	LGC Capital announces construction works have formally begun at Tricho-Med's first 34,000 square feet Medical Cannabis facility in Brownsburg, Quebec finance.yahoo.com - May 2 at 4:08 PM
	Maricann Group Inc. is Awarded GMP Certification www.streetinsider.com - April 30 at 10:09 AM
	Maricann: Damaged Goods For This Cannabis Producer? seekingalpha.com - April 29 at 4:41 PM
	MRF 2018 Resource Limited Partnership Raises $25 Million www.bizjournals.com - April 28 at 10:20 AM
	GMP Capital Provides Supplemental Information finance.yahoo.com - April 28 at 10:20 AM
	Research Reports on Canaccord Genuity Group, Dividend Select 15, TMX Group, and GMP Capital finance.yahoo.com - April 26 at 9:41 AM
	Goodfood Market Announces $10 Million Bought Deal Financing to Accelerate Growth in Western Canada, Launch New Meal Solutions and Invest in Automation globenewswire.com - April 18 at 4:16 PM
	Get Ready for a ‘Clash of the Titans’ in the North American Pot Industry finance.yahoo.com - April 18 at 4:16 PM
	LGC Increases Potential Quebec Medical Cannabis Capacity to Over 2 Million Square Feet finance.yahoo.com - April 9 at 4:03 PM
	GMP Securities to Host 2018 Cannabis Conference finance.yahoo.com - April 4 at 5:31 PM
	Insider launches Growth Management Platform with injection of US$11M Series B led by Sequoia finance.yahoo.com - April 3 at 10:18 AM
	Media Advisory - GMP Capital to Announce First Quarter 2018 Results and Hold Annual and Special Meeting on May 3, 2018 finance.yahoo.com - April 3 at 10:18 AM
	UPDATE - CMAB Biopharma Secures $34 Million Series B Financing globenewswire.com - April 2 at 4:07 PM
	CMAB Biopharma Secures $34 Million Series B Financing globenewswire.com - April 2 at 10:26 AM
	Evonik investment, new startups bode well for Birmingham biotech scene www.bizjournals.com - March 29 at 4:04 PM
	NanoXplore Closes $10 Million Bought Deal Private Placement globenewswire.com - March 27 at 4:02 PM
	MedPharm Receives Growth Equity Investment from Ampersand Capital Partners www.prnewswire.com - March 27 at 10:23 AM
	DiaMedica Therapeutics Announces Closing of Private Placement globenewswire.com - March 21 at 11:11 AM
	Today's Free Reports Canaccord Genuity Group, Dividend Select 15, TMX Group and GMP Capital finance.yahoo.com - March 21 at 11:11 AM
	Terra Life Sciences Inc. Closes CDN$46 Million Private Placement for Expansion of Company's Medical Cannabis Capabilities www.bizjournals.com - March 19 at 3:58 PM
	BRIEF-Gmp Capital Inc. Reports Q4 Earnings Per Share C$0.07 www.reuters.com - March 2 at 4:36 PM
	GMP Capital Inc. Reports Fourth Quarter and Year-End 2017 Results finance.yahoo.com - March 2 at 9:49 AM
	GMP Capital (GMP) Set to Announce Earnings on Friday www.americanbankingnews.com - February 23 at 1:14 AM
	New Gold's (NGD) CEO Hannes Portmann on Q4 2017 Results - Earnings Call Transcript seekingalpha.com - February 21 at 4:18 PM
	Biostar Pharmaceuticals, Inc. Announces Plans to Launch a New eCommerce Sales Platform www.prnewswire.com - February 21 at 10:22 AM
	Today’s Free Reports, Canaccord Genuity Group, Dividend Select 15, TMX Group, and GMP Capital finance.yahoo.com - February 21 at 10:22 AM
	Gem International Announces Results of Annual and Special Meeting of Shareholders finance.yahoo.com - February 12 at 4:54 PM
	Cellular Biomedicine Group (CBMG) Reports $30.6M Investment from Sailing Capital Overseas Investment Ltd. www.streetinsider.com - February 5 at 4:42 PM
	Media Advisory - GMP Capital Inc. to announce fourth quarter and fiscal 2017 results finance.yahoo.com - February 5 at 4:42 PM
	Today’s Research Reports on Tricon Capital Group, Equitable Group, Echelon Financial Holdings and GMP Capital finance.yahoo.com - January 26 at 8:53 AM
	ANALYSIS-Canada's small financial firms get buzz from weed stocks www.cnbc.com - January 24 at 9:12 AM
	CQI Capital Management L.P. Announces Final Distribution of Genesis Partners Fund LP finance.yahoo.com - January 19 at 6:00 PM
	Canadian Exchanges Stock Scanner, Canaccord Genuity Group, Dividend Select 15, TMX Group, and GMP Capital finance.yahoo.com - January 16 at 9:26 AM
	GMP Capital CEO on Digital Currency Firms finance.yahoo.com - December 21 at 5:27 PM
	GMP Capital Inc. (GMP) Director Sells C$85,519.54 in Stock www.americanbankingnews.com - December 18 at 6:20 PM
	Research Reports on Canaccord Genuity Group Dividend Select 15 TMX Group and GMP Capital finance.yahoo.com - December 14 at 9:29 AM

GMP Capital (TSE:GMP) SEC Filings

Form Type:

Ownership Filings:

This page is loading this company's SEC Filings. Please wait...

Financials are not available for this stock.

GMP Capital (TSE GMP) Stock Chart for Monday, May, 28, 2018

Loading chart…

This page was last updated on 5/28/2018 by MarketBeat.com Staff